Massimiliano Calabrese (Albulena Bajrami)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 7

Top Topics

Peritoneal Dialysis

Diffusion Weighted Imaging

Top Venues

Journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Massimiliano Calabrese, Agnese Tamanti, Angela Peloso, Stefano Ziccardi, Maddalena Guandalini, Milena Calderone, Marco Castellaro, Francesca Benedetta Pizzini, Stefania Montemezzi, Damiano Marastoni, Massimiliano Calabrese
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. Journal of neurology (2024)
Massimiliano Calabrese, Agnese Tamanti, Angela Peloso, Stefano Ziccardi, Maddalena Guandalini, Milena Calderone, Marco Castellaro, Francesca Benedetta Pizzini, Stefania Montemezzi, Damiano Marastoni, Massimiliano Calabrese
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. Journal of neurology 271 (5) (2024)
Massimiliano Calabrese, Agnese Tamanti, Angela Peloso, Stefano Ziccardi, Maddalena Guandalini, Milena Calderone, Marco Castellaro, Francesca Benedetta Pizzini, Stefania Montemezzi, Damiano Marastoni, Massimiliano Calabrese
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. Journal of neurology 271 (5) (2024)
Massimiliano Calabrese, Agnese Tamanti, Angela Peloso, Stefano Ziccardi, Maddalena Guandalini, Milena Calderone, Marco Castellaro, Francesca Benedetta Pizzini, Stefania Montemezzi, Damiano Marastoni, Massimiliano Calabrese
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. Journal of neurology 271 (5) (2024)
Massimiliano Calabrese, Agnese Tamanti, Angela Peloso, Stefano Ziccardi, Maddalena Guandalini, Milena Calderone, Marco Castellaro, Francesca Benedetta Pizzini, Stefania Montemezzi, Damiano Marastoni, Massimiliano Calabrese
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. Journal of neurology 271 (5) (2024)
Massimiliano Calabrese, Agnese Tamanti, Angela Peloso, Stefano Ziccardi, Maddalena Guandalini, Milena Calderone, Marco Castellaro, Francesca Benedetta Pizzini, Stefania Montemezzi, Damiano Marastoni, Massimiliano Calabrese
Ocrelizumab reduces cortical and deep grey matter loss compared to the S1P-receptor modulator in multiple sclerosis. Journal of neurology 271 (5) (2024)
Albulena Bajrami, Marco Pitteri, Marco Castellaro, Francesca Pizzini, Chiara Romualdi, Stefania Montemezzi, Salvatore Monaco, Massimiliano Calabrese
The effect of fingolimod on focal and diffuse grey matter damage in active MS patients. Journal of neurology 265 (9) (2018)